A new pretargeted radioimmunotherapy (PRIT) technique has been shown to be safe and effective in eradicating tumors from a ...

Men diagnosed at screening aged 50 years projected to have 16% chance that cancer would not have been detected within 15 ...

Advanced age raises mortality risk in metastatic prostate cancer. Learn how PSA, tumour grade, and treatment influence ...

Patients with cardiovascular-kidney-metabolic syndrome, especially those in the advanced stages at baseline, show a ...

About one third of cancers detected by PSA screening at age 70, and more than half at age 80, are unlikely to become clinically meaningful within 15 years.

The launch of Nigeria’s National Cancer Control Plan is more than a policy update; it signals a fundamental shift in how the country confronts cancer. For too long, cancer care in Nigeria has been ...

TLX597-Tx is a PSMA1-targeting small molecule radioligand therapy (RLT) candidate, designed to improve quality-of-life and efficacy in ...

Celcuity (CELC) cautious Buy: gedatolisib upside hinges on Q2 2026 mutant cohort data in 2L HR+/HER2- breast cancer.

EVERSANA, a purpose-built, partner-led commercial organization, positions Candel for potential U.S. commercial launch following planned BLA ...

Survivors have a heightened risk of developing cardiovascular disease, pain, insomnia, psychosocial distress and new cancers.

For the first time since last July the FDA's Oncologic Drugs Advisory Committee (ODAC) will meet on Thursday to evaluate two ...

Prostate cancer represents one of the most common malignancies in men in developed countries with increasing incidence in recent years due to the ...